Perspective Therapeutics
CATX
25 hedge funds and large institutions have $4.58M invested in Perspective Therapeutics in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
475% more capital invested
Capital invested by funds: $796K → $4.58M (+$3.78M)
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
39% more funds holding
Funds holding: 18 → 25 (+7)
0.04% less ownership
Funds ownership: 0.41% → 0.38% (-0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$695K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$43.7K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$36.3K |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$21.9K |
| 5 |
CM
Churchill Management
Los Angeles,
California
|
+$20.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$403K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 3 |
NES
New England Securities
New York
|
-$10.2K |
| 4 |
Citigroup
New York
|
-$2K |
| 5 |
ST
Smithfield Trust
Pittsburgh,
Pennsylvania
|
-$1K |
CATX Hedge Fund Activity: Q1 2014 in Review
25 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2014, worth a combined $4.58M — up 475% from $796K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CATX positions and 3 closed out — a net gain of 7 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $695K. The largest seller was Sabby Management, cutting an estimated $403K.
- 25 institutional investors held Perspective Therapeutics (CATX) as of Q1 2014, up from 18 in Q4 2013.
- Funds reported $4.58M of Perspective Therapeutics stock for Q1 2014, up 475% quarter-over-quarter.
- 10 funds opened new Perspective Therapeutics positions in Q1 2014 and 3 closed out, a net change of +7 holders.
- The largest Perspective Therapeutics buyer in Q1 2014 was Vanguard Group, an estimated $695K added.
- The largest Perspective Therapeutics seller in Q1 2014 was Sabby Management, an estimated $403K sold.
Based on aggregated 13F filings for Q1 2014.